tiprankstipranks
CANbridge Pharmaceuticals Inc. (HK:1228)
:1228
Hong Kong Market
1228
CANbridge Pharmaceuticals Inc.
RESEARCH TOOLSreports
Want to see HK:1228 full AI Analyst Report?

CANbridge Pharmaceuticals Inc. (1228) Income Statement

0 Followers

CANbridge Pharmaceuticals Inc. Income Statement

Last quarter (Q2 2025), CANbridge Pharmaceuticals Inc.'s total revenue was ¥11.12M, a decrease of -50.33% from the same quarter last year. In Q2, CANbridge Pharmaceuticals Inc.'s net income was ¥29.62M. See CANbridge Pharmaceuticals Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 48.69M¥ 85.10M¥ 102.87M¥ 78.97M¥ 31.16M
Gross Profit
¥ 35.68M¥ 54.30M¥ 64.16M¥ 48.89M¥ 18.78M
Operating Expenses
¥ 125.98M¥ 394.82M¥ 429.28M¥ 506.86M¥ 673.52M
Depreciation and Amortization
¥ 11.83M¥ 11.82M¥ 28.46M¥ 21.98M¥ 15.71M
EBITDA
¥ -78.47M¥ -328.69M¥ -341.43M¥ -454.63M¥ -1.06B
Operating Income
¥ -90.30M¥ -340.51M¥ -366.55M¥ -457.97M¥ -655.15M
Other Income/Expenses
¥ 104.73M¥ -102.10M¥ -12.29M¥ -25.51M¥ -421.86M
Pretax Income
¥ 14.43M¥ -442.62M¥ -378.84M¥ -483.48M¥ -1.08B
Net Income
¥ 14.43M¥ -442.62M¥ -378.84M¥ -483.48M¥ -1.08B
Per Share Metrics
Basic EPS
¥ 0.03¥ -1.04¥ -0.89¥ -1.14¥ -11.43
Diluted EPS
¥ 0.03¥ -1.04¥ -0.89¥ -1.14¥ -11.43
Weighted Average Shares Outstanding
 453.57M 424.83M 424.38M 424.21M 94.24M
Weighted Average Shares Outstanding (Diluted)
 456.90M 424.83M 424.38M 424.21M 94.24M
Currency in CNY

CANbridge Pharmaceuticals Inc. Earnings and Revenue History